BRPI0412268A - compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a - Google Patents
compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2aInfo
- Publication number
- BRPI0412268A BRPI0412268A BRPI0412268-2A BRPI0412268A BRPI0412268A BR PI0412268 A BRPI0412268 A BR PI0412268A BR PI0412268 A BRPI0412268 A BR PI0412268A BR PI0412268 A BRPI0412268 A BR PI0412268A
- Authority
- BR
- Brazil
- Prior art keywords
- serotonin reuptake
- reuptake inhibitor
- receptor antagonist
- compounds containing
- selective serotonin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSTOS CONTENDO UM INIBIDOR SELETIVO DA RECAPTAçãO DE SEROTONINA E ANTAGONISTA DE RECEPTOR 5-HT2A". Composições compreendendo um inibidor seletivo da recaptação de serotonina (ISRS), particularmente sertralina, e um inibidor seletivo para a ligação da serotonina no sítio 5HT~ 2A~. A invenção está relacionada ao uso de tais composições para o tratamento ou a prevenção de transtornos do humor incluindo transtornos de depressão e ansiedade.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48495003P | 2003-07-03 | 2003-07-03 | |
PCT/IB2004/002116 WO2005002578A1 (en) | 2003-07-03 | 2004-06-21 | Compositions containing a serotonin selective reuptake inhibitor and a 5-ht2a receptor antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0412268A true BRPI0412268A (pt) | 2006-09-05 |
Family
ID=33564037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0412268-2A BRPI0412268A (pt) | 2003-07-03 | 2004-06-21 | compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050070577A1 (pt) |
EP (1) | EP1644000A1 (pt) |
JP (1) | JP2007516204A (pt) |
BR (1) | BRPI0412268A (pt) |
CA (1) | CA2530483A1 (pt) |
MX (1) | MXPA06000077A (pt) |
WO (1) | WO2005002578A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2698808A1 (en) | 2007-09-13 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
GB0814466D0 (en) * | 2008-08-07 | 2008-09-10 | Rosemont Pharmaceuticals Ltd | Sertraline composition |
JP5061062B2 (ja) | 2008-08-08 | 2012-10-31 | パナソニック株式会社 | 三次元形状造形物の製造方法 |
WO2014046544A1 (en) | 2012-09-21 | 2014-03-27 | Aapa B.V. | Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
CN106353496A (zh) * | 2016-11-10 | 2017-01-25 | 中国兽医药品监察所 | 布鲁氏菌荧光偏振(fpa)检测试剂盒 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4045488A (en) * | 1974-11-06 | 1977-08-30 | Pfizer Inc. | Aminophenyltetralin compounds |
US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
US5169096A (en) * | 1985-07-02 | 1992-12-08 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl-piperidine-methanol derivatives |
FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
US5597826A (en) * | 1994-09-14 | 1997-01-28 | Pfizer Inc. | Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
US5844000A (en) * | 1997-06-12 | 1998-12-01 | Sanofi | Propenone oxime ethers and pharmaceutical compositions containing them |
-
2004
- 2004-06-17 US US10/870,127 patent/US20050070577A1/en not_active Abandoned
- 2004-06-21 CA CA002530483A patent/CA2530483A1/en not_active Abandoned
- 2004-06-21 BR BRPI0412268-2A patent/BRPI0412268A/pt not_active Application Discontinuation
- 2004-06-21 EP EP04743804A patent/EP1644000A1/en not_active Withdrawn
- 2004-06-21 WO PCT/IB2004/002116 patent/WO2005002578A1/en not_active Application Discontinuation
- 2004-06-21 JP JP2006518386A patent/JP2007516204A/ja active Pending
- 2004-06-21 MX MXPA06000077A patent/MXPA06000077A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005002578A1 (en) | 2005-01-13 |
JP2007516204A (ja) | 2007-06-21 |
EP1644000A1 (en) | 2006-04-12 |
US20050070577A1 (en) | 2005-03-31 |
CA2530483A1 (en) | 2005-01-13 |
MXPA06000077A (es) | 2006-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0413563A (pt) | compostos e composições como inibidores de atividade do receptor de quìnase de tirosina | |
PT1237553E (pt) | Combinacao de um inibidor de recaptacao da serotonina e de um antagonista, de um agonista inverso ou de um agonista parcial para o 5-ht2c | |
NO20042964L (no) | Spiroazasykliske forbindelser som monoaminreseptormodulatorer | |
BR0307429A (pt) | Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3 | |
HUP0303855A2 (hu) | Indazolil-szubsztituált pirrolinvegyületek mint kináz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
NO20060402L (no) | 3-amino choman og 2-aminotetralinderivater | |
PT1328269E (pt) | Associacao de um antagonista do receptor cb1 e de sibutramina composicoes farmaceuticas que os contem e sua utilizacao para o tratamento da obesidade | |
BRPI0409173A (pt) | compostos e composições como inibidores de proteìna quinase | |
BR0209580A (pt) | Derivados de ciclohexan-1, 4 diamina substituìdos | |
DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
DE60237528D1 (de) | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative | |
BR0306147A (pt) | Uso de um composto ou combinação de compostos tendo atividade agonìstica de receptor de dopamina-d2 parcial e atividade inibidora de reabsorção da serotonina e/ou noradrenalina, método para a preparação de uma composição, e, composição | |
ATE293448T1 (de) | Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten | |
BRPI0718469A2 (pt) | Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto. | |
MXPA05013016A (es) | Gaboxadol para el tratamiento de la depresion y otros trastornos afectivos. | |
BR0315346A (pt) | Método para o tratamento ou prevenção de sintomas de vasomotores em um paciente, formulação farmacêutica e utilização de inibidor de re-apreensão de norepinefrina em combinação com antagonista de 5-h2a | |
ATE355054T1 (de) | Verfahren und verbindungen zur behandlung der depression | |
BRPI0607684A2 (pt) | composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida | |
EP1254668A3 (en) | Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression | |
BRPI0412268A (pt) | compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a | |
BRPI0409730A (pt) | tratamento da incontinência | |
BR0316070A (pt) | Composto, composição farmacêutica, uso de um composto e, método para modular mchr | |
BR0115301A (pt) | Uso de um inibidor seletivo da recaptação de norepinefrina | |
BR0311503A (pt) | Uso de um composto, uso de um agonista parcial, agonista inverso, ou antagonista de receptor de gabab, composição farmacêutica, método para a identificação de compostos úteis para o tratamento de doenças, e, composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |